Please provide your email address to receive an email when new articles are posted on . Fewer patients with hyperkalemia were prescribed renin-angiotensin-aldosterone system inhibitors for HF.

Investigators sought to distinguish the underlying cause of hyperkalemia after solid organ transplantation, whether from medications or organ dysfunction. Among solid organ transplant recipients, ...

EXTON, Penn.--(BUSINESS WIRE)--While the perceived need for new therapies for hyperkalemia is relatively low compared to a number of other conditions in nephrology, interest is high in Relypsa’s ...

Please provide your email address to receive an email when new articles are posted on . Overall, 38 patients had hyperkalemia before dialysis, researchers found. A daily intake of greater than 15.33 g ...

A real-world study finds reduced RAASi-related hyperkalemia risk among at-risk patients initiating SGLT2 inhibitors. Sodium glucose cotransporter 2 inhibitor (SGLT2i) use is associated with lower ...